shock after cardiac arrest
Conditions
Interventions
Hemofiltration with one of the earlier mentioned filters in 1 of the 3 modi (A,
B, C)
Sponsors
Onze Lieve Vrouwe Gasthuis
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients with shock after cardiac arrest, treated with hypothermia
Exclusion criteria
Exclusion criteria: no CVVH available contra-indication nadroparin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| As a marker for the clearance of smallmolecules, the concentration of creatinin, urea and ADMA will be measured. As a marker for the clearance of the midmolecules, the concentrations of β2-microglobuline en Interleukine-6 will be measured. The concentrations will be measured in the arterial blood, postfilter blood and in the ultrafiltrate. We will measure the hematocrit in the bloodsamples. Primary endpoint Effectivity of the clearance of midmolecules, 15 minutes and 6 hours after start HVHF, expressed as: o Sieving coefficient o Concentration filtrate* filtrateflow | — |
Secondary
| Measure | Time frame |
|---|---|
| Secundary endpoints · Effectivity of the clearance of midmolecules, 12 hours after start HVHF · Hemodynamics · Metabolic control · Other organfailure | — |
Countries
Netherlands
Outcome results
None listed